News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
83,599 Results
Type
Article (3181)
Company Profile (14)
Press Release (80404)
Section
Business (22778)
Career Advice (435)
Deals (4480)
Drug Delivery (14)
Drug Development (14450)
Employer Resources (28)
FDA (2940)
Job Trends (2781)
News (43708)
Policy (3422)
Tag
Academia (298)
Accelerated approval (1)
Adcomms (1)
Allergies (43)
Alliances (4144)
ALS (29)
Alzheimer's disease (235)
Antibody-drug conjugate (ADC) (17)
Approvals (3002)
Artificial intelligence (61)
Autoimmune disease (8)
Automation (8)
Bankruptcy (26)
Best Places to Work (2650)
BIOSECURE Act (1)
Biosimilars (16)
Biotechnology (8)
Bladder cancer (33)
Brain cancer (7)
Breast cancer (98)
Cancer (608)
Cardiovascular disease (36)
Career advice (366)
Career pathing (8)
CAR-T (22)
Cell therapy (81)
Cervical cancer (9)
Clinical research (13139)
Collaboration (196)
Compensation (156)
Complete response letters (1)
COVID-19 (270)
CRISPR (11)
C-suite (49)
Cystic fibrosis (35)
Data (799)
Depression (20)
Diabetes (73)
Diagnostics (895)
Digital health (2)
Diversity, equity & inclusion (4)
Drug discovery (24)
Drug pricing (11)
Drug shortages (1)
Duchenne muscular dystrophy (32)
Earnings (15047)
Editorial (5)
Employer branding (5)
Employer resources (23)
Events (13060)
Executive appointments (180)
FDA (3407)
Frontotemporal dementia (1)
Funding (211)
Gene editing (24)
Generative AI (6)
Gene therapy (92)
GLP-1 (106)
Government (447)
Grass and pollen (1)
Guidances (58)
Healthcare (2634)
Huntington's disease (4)
IgA nephropathy (5)
Immunology and inflammation (22)
Indications (9)
Infectious disease (295)
Inflammatory bowel disease (40)
Inflation Reduction Act (1)
Influenza (6)
Intellectual property (10)
Interviews (69)
IPO (2812)
IRA (6)
Job creations (326)
Job search strategy (332)
Kidney cancer (1)
Labor market (21)
Layoffs (44)
Leadership (3)
Legal (305)
Liver cancer (18)
Lung cancer (75)
Lymphoma (48)
Machine learning (2)
Management (8)
Manufacturing (53)
MASH (23)
Medical device (1822)
Medtech (1822)
Mergers & acquisitions (1869)
Metabolic disorders (155)
Multiple sclerosis (21)
NASH (2)
Neurodegenerative disease (21)
Neuropsychiatric disorders (4)
Neuroscience (391)
NextGen: Class of 2025 (830)
Non-profit (761)
Now hiring (7)
Obesity (59)
Opinion (28)
Ovarian cancer (18)
Pain (20)
Pancreatic cancer (24)
Parkinson's disease (47)
Partnered (2)
Patents (28)
Patient recruitment (21)
Peanut (26)
People (3741)
Pharmaceutical (4)
Pharmacy benefit managers (2)
Phase I (3060)
Phase II (5248)
Phase III (5766)
Pipeline (478)
Policy (10)
Postmarket research (607)
Preclinical (887)
Press Release (11)
Prostate cancer (33)
Psychedelics (7)
Radiopharmaceuticals (36)
Rare diseases (123)
Real estate (469)
Recruiting (13)
Regulatory (3154)
Reports (13)
Research institute (301)
Resumes & cover letters (71)
Rett syndrome (5)
RNA editing (1)
RSV (9)
Schizophrenia (28)
Series A (34)
Series B (26)
Service/supplier (1)
Sickle cell disease (15)
Special edition (3)
Spinal muscular atrophy (36)
Sponsored (5)
Startups (387)
Stomach cancer (2)
Supply chain (16)
Tariffs (1)
Vaccines (83)
Venture capitalists (12)
Weight loss (24)
Women's health (3)
Worklife (3)
Date
Today (59)
Last 7 days (314)
Last 30 days (905)
Last 365 days (8357)
2025 (3370)
2024 (7786)
2023 (7512)
2022 (8580)
2021 (9166)
2020 (7737)
2019 (6710)
2018 (4712)
2017 (4176)
2016 (3423)
2015 (3973)
2014 (2632)
2013 (1791)
2012 (1836)
2011 (1920)
2010 (1537)
Location
Africa (131)
Alabama (6)
Alaska (1)
Arizona (14)
Arkansas (1)
Asia (5137)
Australia (872)
California (1760)
Canada (447)
China (98)
Colorado (74)
Connecticut (89)
Delaware (70)
Europe (13502)
Florida (212)
Georgia (43)
Idaho (3)
Illinois (106)
India (7)
Indiana (109)
Iowa (5)
Japan (90)
Kansas (13)
Kentucky (3)
Louisiana (5)
Maine (4)
Maryland (164)
Massachusetts (1303)
Michigan (47)
Minnesota (60)
Mississippi (1)
Missouri (18)
Montana (9)
Nebraska (3)
Nevada (23)
New Hampshire (9)
New Jersey (514)
New Mexico (6)
New York (471)
North Carolina (230)
Northern California (783)
Ohio (52)
Oklahoma (1)
Oregon (7)
Pennsylvania (321)
Puerto Rico (2)
Rhode Island (6)
South America (168)
South Carolina (2)
Southern California (674)
Tennessee (13)
Texas (200)
United States (5992)
Utah (30)
Virginia (37)
Washington D.C. (12)
Washington State (137)
West Virginia (1)
Wisconsin (37)
83,599 Results for "4life".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update
March 28, 2025
·
13 min read
Press Releases
Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025
February 25, 2025
·
1 min read
Press Releases
MYND Life Sciences Announces the Issuance of 4,000,001 Shares at $0.71/share
January 20, 2025
·
1 min read
Press Releases
Apogee Therapeutics Announces Positive Interim Results from the Phase 1b Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody, in Patients with Mild-to-Moderate Asthma
May 12, 2025
·
6 min read
Press Releases
Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease
April 7, 2025
·
10 min read
Press Releases
TriSalus Life Sciences Announces Preliminary Q4 and Full Year Unaudited 2024 Financial Results and Conference Call
January 23, 2025
·
7 min read
Press Releases
Restart Life Sciences Corp. Relies on Exception Under CSE Policy 4.6(2)(b) for Previously Closed Private Placement and Debt Settlement Transactions and Announces Debt Settlement Transaction
February 7, 2025
·
3 min read
Drug Development
Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trial of SPY001, its Novel Half-life Extended anti-α4β7 Antibody, for the Treatment of Inflammatory Bowel Disease
Spyre Therapeutics, Inc. today announced that it has initiated dosing of healthy volunteers in its first clinical trial of SPY001, an investigational novel half-life extended anti-α4β7 monoclonal antibody.
June 18, 2024
·
7 min read
Genetown
Comera Life Sciences Announces the Completion of $4.1 Million Private Placement
Comera Life Sciences Holdings, Inc. announced that it has completed its previously announced $4.1 million private placement of shares of its common stock, and accompanying warrants to purchase shares of its common stock, to existing stockholders at a purchase price of $0.51125 per share.
September 12, 2023
·
5 min read
Press Releases
Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease
September 20, 2024
·
6 min read
1 of 8,360
Next
